Palladone FDA Approval History
FDA Approved: Yes (Discontinued) (First approved September 24, 2004)
Brand name: Palladone
Generic name: hydromorphone hydrochloride
Dosage form: Extended Release Capsules
Company: Purdue Pharma L.P.
Treatment for: Pain
Marketing Status: Discontinued
Palladone (hydromorphone hydrochloride) is an extended release opioid analgesic indicated for the management of moderate to severe pain in patients requiring continuous, around-the-clock analgesia.
Purdue Pharma suspended the sales and marketing of Palladone in July 2005 at the request of the FDA because of the serious and potentially fatal adverse reactions that can occur when Palladone is taken with alcohol.
Development timeline for Palladone
| Date | Article |
|---|---|
| Sep 24, 2004 | Approval FDA Approves Palladone (hydromorphone HCl extended-release) Capsules (CII) For The Management Of Persistent, Moderate To Severe Pain |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
